IRIS
GIACOMELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.548
NA - Nord America 2.423
EU - Europa 1.407
SA - Sud America 51
AF - Africa 47
OC - Oceania 36
AN - Antartide 1
Totale 13.513
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 6.502
US - Stati Uniti d'America 2.334
HK - Hong Kong 1.740
CN - Cina 1.018
GB - Regno Unito 576
IT - Italia 258
DE - Germania 194
IN - India 115
NL - Olanda 88
CA - Canada 76
UA - Ucraina 47
TR - Turchia 42
FR - Francia 39
JP - Giappone 39
AU - Australia 35
FI - Finlandia 30
ES - Italia 27
BR - Brasile 26
ZA - Sudafrica 25
CZ - Repubblica Ceca 24
PL - Polonia 21
PT - Portogallo 17
ID - Indonesia 15
MX - Messico 13
AT - Austria 11
EG - Egitto 10
CL - Cile 9
SE - Svezia 9
AR - Argentina 8
IL - Israele 8
SA - Arabia Saudita 8
DK - Danimarca 7
IR - Iran 7
KZ - Kazakistan 7
PK - Pakistan 7
CH - Svizzera 6
BD - Bangladesh 5
BG - Bulgaria 5
EE - Estonia 5
GR - Grecia 5
SK - Slovacchia (Repubblica Slovacca) 5
IE - Irlanda 4
JO - Giordania 4
RO - Romania 4
RU - Federazione Russa 4
SN - Senegal 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
EC - Ecuador 3
KR - Corea 3
KW - Kuwait 3
LU - Lussemburgo 3
OM - Oman 3
QA - Qatar 3
RS - Serbia 3
TH - Thailandia 3
BE - Belgio 2
BO - Bolivia 2
CO - Colombia 2
CY - Cipro 2
GH - Ghana 2
HU - Ungheria 2
LT - Lituania 2
MA - Marocco 2
NG - Nigeria 2
PH - Filippine 2
SI - Slovenia 2
TN - Tunisia 2
TW - Taiwan 2
VN - Vietnam 2
AQ - Antartide 1
AZ - Azerbaigian 1
BY - Bielorussia 1
HR - Croazia 1
IQ - Iraq 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PE - Perù 1
UZ - Uzbekistan 1
Totale 13.513
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.719
Singapore 937
Ashburn 767
Boardman 611
Hefei 548
London 516
Shanghai 348
Council Bluffs 119
Pune 94
Los Angeles 77
San Francisco 77
Amsterdam 63
Rome 57
Toronto 52
Washington 51
Munich 50
Seattle 46
Tokyo 23
Ankara 20
Turku 20
West Jordan 20
Brno 19
Santa Clara 19
Bari 17
Warsaw 16
New York 15
Melbourne 13
Brooklyn 11
Naples 11
Barcelos 10
Manchester 10
Sydney 10
Hanover 9
Helsinki 9
Milan 9
Paris 9
The Dalles 9
Canberra 8
Chicago 8
Dallas 8
Hangzhou 8
Jinan 8
Montreal 8
Changsha 7
Jaguariúna 7
Madrid 7
Phoenix 7
Stockholm 7
Frankfurt am Main 6
Guangzhou 6
Las Vegas 6
Nuremberg 6
Secaucus 6
St Louis 6
São Paulo 6
Andover 5
Berlin 5
Bratislava 5
Cairo 5
Central 5
Charlotte 5
Chennai 5
Johannesburg 5
Oklahoma City 5
Olomouc 5
Riyadh 5
Vienna 5
Amman 4
Athens 4
Beijing 4
Bengaluru 4
Bologna 4
Boston 4
Buffalo 4
Dakar 4
Dublin 4
Haikou 4
Kongens Lyngby 4
Markham 4
Nanjing 4
Newark 4
Noicattaro 4
Ottawa 4
Salerno 4
State College 4
Aberdeen 3
Almaty 3
Bangkok 3
Belgrade 3
Birmingham 3
Brisbane 3
Buenos Aires 3
Centurion 3
Dhaka 3
Doha 3
Fiume Veneto 3
Florence 3
Gorle 3
Haifa 3
Kuwait City 3
Totale 6.713
Salva come PNG Salva come JPEG
Nome #
------- 206
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 200
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 196
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 191
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 186
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 185
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 177
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 175
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 175
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 165
A comprehensive review on adult onset Still's disease 159
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 158
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 157
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 156
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 151
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 151
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 145
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 145
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 144
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 141
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 130
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 116
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 104
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 98
Adult-onset Still's disease with elderly onset: results from a multicentre study 91
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 90
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 84
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 83
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 81
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 80
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 79
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 78
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 77
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 75
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 75
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 74
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 74
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 72
Cytokine storm syndrome in severe COVID-19 72
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 71
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 70
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 68
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 68
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 67
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 66
Cardiovascular disease in primary sjögren’s syndrome 62
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 61
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 59
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 51
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 49
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 46
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 45
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 42
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 40
The Vessels Contribute to Fibrosis in Systemic Sclerosis 40
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 40
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 40
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 39
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 39
The economic burden of fibromyalgia: A systematic literature review 36
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 34
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 34
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 34
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 33
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 33
Development and implementation of the AIDA International Registry for patients with Behçet's disease 31
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 31
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 31
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 30
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 28
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 28
Vitamin D and systemic lupus erythematosus - The hype and the hope 28
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 26
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 26
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 26
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 26
Neoplasie e sistema immune 26
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 26
Potential of stem cells in the treatment of rheumatic disease 25
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis 25
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 25
Assessment of health-related quality of life in patients with adult onset Still disease: Results from a multicentre cross-sectional study 24
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 23
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 23
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 23
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 23
IL-36α axis is modulated in patients with primary Sjogren's Syndrome. 23
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 23
Immunopharmacological profile of sebatic acid, a candidate for total parenteral nutrition. 23
Prevalence and characteristics of diffuse idiopathic skeletal hyperostosis (DISH) in Italy 22
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 22
Imbalance of immune functions in progressive systemic sclerosis patients 22
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 22
Recenti acquisizioni e orientamenti nel laboratorio di immunologia 22
Gamma/delta T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosis 22
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 22
Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database 21
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 21
l'immunoterapia dei tumori 21
High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins 21
Totale 7.124
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 5 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/202643 43 0 0 0 0 0 0 0 0 0 0 0
Totale 13.662